Filing Details
- Accession Number:
- 0001209191-21-014307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-25 16:18:44
- Reporting Period:
- 2021-02-24
- Accepted Time:
- 2021-02-25 16:18:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1549595 | Nurix Therapeutics Inc. | NRIX | Pharmaceutical Preparations (2834) | 270838048 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1817217 | Hans Houte Van | C/O Nurix Therapeutics, Inc. 1700 Owens Street, Suite 205 San Francisco CA 94158 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-24 | 20,393 | $1.20 | 20,393 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-24 | 13,197 | $1.86 | 33,590 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-24 | 1,829 | $7.26 | 35,419 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-24 | 35,419 | $39.90 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-02-24 | 20,393 | $0.00 | 20,393 | $1.20 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-02-24 | 13,197 | $0.00 | 13,197 | $1.86 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-02-24 | 1,829 | $0.00 | 1,829 | $7.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,027 | 2028-03-01 | No | 4 | M | Direct | |
| 20,136 | 2029-08-28 | No | 4 | M | Direct | |
| 36,504 | 2030-02-26 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The stock option vests as to 1/48 of the total shares monthly beginning February 2, 2018 until the option is fully vested on January 2, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
- The stock option vests as to 1/48 of the total shares monthly beginning June 10, 2019 until the option is fully vested on May 10, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
- The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
Billionaire Hedge Funds
